BERLDRG.BO

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Medical - Pharmaceuticals

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
BERLDRG.BOBeryl Drugs Limited	$24.50	+0.57%	$124M	—
COLINZ.BOColinz Laboratories Limited	$71.50	-4.67%	$180M	—
DECIPHER.BODecipher Labs Ltd.	$5.50	-3.51%	$56M	—
EMMESSA.BOEmmessar Biotech & Nutrition Limited	$24.75	+0.61%	$124M	—
EVOQ.BOEvoq Remedies Ltd.	$1.43	-2.72%	$36M	—
NEXUSSURGL.BONexus Surgical and Medicare Limited	$31.44	-4.99%	$172M	—
PARMAX.BOParmax Pharma Limited	$135.05	+0.97%	$505M	—

Source: Financial Modeling Prep · peers by sector/industry

Beryl Drugs Limited

Beryl Drugs Limited focuses on the manufacturing of bulk pharmaceutical ingredients. Its comprehensive product portfolio encompasses liquid and dry small-volume injectable medications, ophthalmic and otic solutions, intravenous (IV) fluids supplied in both polypack and glass bottles, and a variety of veterinary pharmaceuticals. The company was established on August 24, 1993, and maintains its corporate headquarters in Indore, India.

www.beryldrugs.com

Employees: 22
IPO / List date: Jun 14, 2005
HQ: IN

Held by traders on TradeandTell

No one on the platform currently holds BERLDRG.BO.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in BERLDRG.BO as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded BERLDRG.BO yet.